Click for best price
Celiac Drugs Market Size, Share 2022
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body?s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body?s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sj?gren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
This report contains market size and forecasts of Celiac Drugs in global, including the following market information:
Global Celiac Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Celiac Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Celiac Drugs companies in 2021 (%)
The global Celiac Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
First Line Of Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Celiac Drugs include ADMA Biologics, Amgen, Anthera Pharmaceuticals, Bayer, Biogen, BioLineRx, Biotest, Bristol-Myers Squibb and Celgene, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Celiac Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Celiac Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Celiac Drugs Market Segment Percentages, by Type, 2021 (%)
First Line Of Treatment
Second Line Of Treatment
Global Celiac Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Celiac Drugs Market Segment Percentages, by Application, 2021 (%)
Men
Women
Children
Global Celiac Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Celiac Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Celiac Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Celiac Drugs revenues share in global market, 2021 (%)
Key companies Celiac Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Celiac Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
| Report Attributes |
Report Details |
| Report Title |
Celiac Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
126 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Celiac Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Celiac Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Celiac Drugs Overall Market Size
2.1 Global Celiac Drugs Market Size: 2021 VS 2028
2.2 Global Celiac Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Celiac Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Celiac Drugs Players in Global Market
3.2 Top Global Celiac Drugs Companies Ranked by Revenue
3.3 Global Celiac Drugs Revenue by Companies
3.4 Global Celiac Drugs Sales by Companies
3.5 Global Celiac Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Celiac Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Celiac Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Celiac Drugs Players in Global Market
3.8.1 List of Global Tier 1 Celiac Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Celiac Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Celiac Drugs Market Size Markets, 2021 & 2028
4.1.2 First Line Of Treatment
4.1.3 Second Line Of Treatment
4.2 By Type - Global Celiac Drugs Revenue & Forecasts
4.2.1 By Type - Global Celiac Drugs Revenue, 2017-2022
4.2.2 By Type - Global Celiac Drugs Revenue, 2023-2028
4.2.3 By Type - Global Celiac Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Celiac Drugs Sales & Forecasts
4.3.1 By Type - Global Celiac Drugs Sales, 2017-2022
4.3.2 By Type - Global Celiac Drugs Sales, 2023-2028
4.3.3 By Type - Global Celiac Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Celiac Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Celiac Drugs Market Size, 2021 & 2028
5.1.2 Men
5.1.3 Women
5.1.4 Children
5.2 By Application - Global Celiac Drugs Revenue & Forecasts
5.2.1 By Application - Global Celiac Drugs Revenue, 2017-2022
5.2.2 By Application - Global Celiac Drugs Revenue, 2023-2028
5.2.3 By Application - Global Celiac Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Celiac Drugs Sales & Forecasts
5.3.1 By Application - Global Celiac Drugs Sales, 2017-2022
5.3.2 By Application - Global Celiac Drugs Sales, 2023-2028
5.3.3 By Application - Global Celiac Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Celiac Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Celiac Drugs Market Size, 2021 & 2028
6.2 By Region - Global Celiac Drugs Revenue & Forecasts
6.2.1 By Region - Global Celiac Drugs Revenue, 2017-2022
6.2.2 By Region - Global Celiac Drugs Revenue, 2023-2028
6.2.3 By Region - Global Celiac Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Celiac Drugs Sales & Forecasts
6.3.1 By Region - Global Celiac Drugs Sales, 2017-2022
6.3.2 By Region - Global Celiac Drugs Sales, 2023-2028
6.3.3 By Region - Global Celiac Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Celiac Drugs Revenue, 2017-2028
6.4.2 By Country - North America Celiac Drugs Sales, 2017-2028
6.4.3 US Celiac Drugs Market Size, 2017-2028
6.4.4 Canada Celiac Drugs Market Size, 2017-2028
6.4.5 Mexico Celiac Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Celiac Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Celiac Drugs Sales, 2017-2028
6.5.3 Germany Celiac Drugs Market Size, 2017-2028
6.5.4 France Celiac Drugs Market Size, 2017-2028
6.5.5 U.K. Celiac Drugs Market Size, 2017-2028
6.5.6 Italy Celiac Drugs Market Size, 2017-2028
6.5.7 Russia Celiac Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Celiac Drugs Market Size, 2017-2028
6.5.9 Benelux Celiac Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Celiac Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Celiac Drugs Sales, 2017-2028
6.6.3 China Celiac Drugs Market Size, 2017-2028
6.6.4 Japan Celiac Drugs Market Size, 2017-2028
6.6.5 South Korea Celiac Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Celiac Drugs Market Size, 2017-2028
6.6.7 India Celiac Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Celiac Drugs Revenue, 2017-2028
6.7.2 By Country - South America Celiac Drugs Sales, 2017-2028
6.7.3 Brazil Celiac Drugs Market Size, 2017-2028
6.7.4 Argentina Celiac Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Celiac Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Celiac Drugs Sales, 2017-2028
6.8.3 Turkey Celiac Drugs Market Size, 2017-2028
6.8.4 Israel Celiac Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Celiac Drugs Market Size, 2017-2028
6.8.6 UAE Celiac Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 ADMA Biologics
7.1.1 ADMA Biologics Corporate Summary
7.1.2 ADMA Biologics Business Overview
7.1.3 ADMA Biologics Celiac Drugs Major Product Offerings
7.1.4 ADMA Biologics Celiac Drugs Sales and Revenue in Global (2017-2022)
7.1.5 ADMA Biologics Key News
7.2 Amgen
7.2.1 Amgen Corporate Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Celiac Drugs Major Product Offerings
7.2.4 Amgen Celiac Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Amgen Key News
7.3 Anthera Pharmaceuticals
7.3.1 Anthera Pharmaceuticals Corporate Summary
7.3.2 Anthera Pharmaceuticals Business Overview
7.3.3 Anthera Pharmaceuticals Celiac Drugs Major Product Offerings
7.3.4 Anthera Pharmaceuticals Celiac Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Anthera Pharmaceuticals Key News
7.4 Bayer
7.4.1 Bayer Corporate Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Celiac Drugs Major Product Offerings
7.4.4 Bayer Celiac Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Bayer Key News
7.5 Biogen
7.5.1 Biogen Corporate Summary
7.5.2 Biogen Business Overview
7.5.3 Biogen Celiac Drugs Major Product Offerings
7.5.4 Biogen Celiac Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Biogen Key News
7.6 BioLineRx
7.6.1 BioLineRx Corporate Summary
7.6.2 BioLineRx Business Overview
7.6.3 BioLineRx Celiac Drugs Major Product Offerings
7.6.4 BioLineRx Celiac Drugs Sales and Revenue in Global (2017-2022)
7.6.5 BioLineRx Key News
7.7 Biotest
7.7.1 Biotest Corporate Summary
7.7.2 Biotest Business Overview
7.7.3 Biotest Celiac Drugs Major Product Offerings
7.7.4 Biotest Celiac Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Biotest Key News
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Corporate Summary
7.8.2 Bristol-Myers Squibb Business Overview
7.8.3 Bristol-Myers Squibb Celiac Drugs Major Product Offerings
7.8.4 Bristol-Myers Squibb Celiac Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Bristol-Myers Squibb Key News
7.9 Celgene
7.9.1 Celgene Corporate Summary
7.9.2 Celgene Business Overview
7.9.3 Celgene Celiac Drugs Major Product Offerings
7.9.4 Celgene Celiac Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Celgene Key News
7.10 Celimmune
7.10.1 Celimmune Corporate Summary
7.10.2 Celimmune Business Overview
7.10.3 Celimmune Celiac Drugs Major Product Offerings
7.10.4 Celimmune Celiac Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Celimmune Key News
7.11 F Hoffmann-La Roche
7.11.1 F Hoffmann-La Roche Corporate Summary
7.11.2 F Hoffmann-La Roche Celiac Drugs Business Overview
7.11.3 F Hoffmann-La Roche Celiac Drugs Major Product Offerings
7.11.4 F Hoffmann-La Roche Celiac Drugs Sales and Revenue in Global (2017-2022)
7.11.5 F Hoffmann-La Roche Key News
7.12 ImmunogenX
7.12.1 ImmunogenX Corporate Summary
7.12.2 ImmunogenX Celiac Drugs Business Overview
7.12.3 ImmunogenX Celiac Drugs Major Product Offerings
7.12.4 ImmunogenX Celiac Drugs Sales and Revenue in Global (2017-2022)
7.12.5 ImmunogenX Key News
7.13 Immunomedics
7.13.1 Immunomedics Corporate Summary
7.13.2 Immunomedics Celiac Drugs Business Overview
7.13.3 Immunomedics Celiac Drugs Major Product Offerings
7.13.4 Immunomedics Celiac Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Immunomedics Key News
7.14 ImmusanT
7.14.1 ImmusanT Corporate Summary
7.14.2 ImmusanT Business Overview
7.14.3 ImmusanT Celiac Drugs Major Product Offerings
7.14.4 ImmusanT Celiac Drugs Sales and Revenue in Global (2017-2022)
7.14.5 ImmusanT Key News
7.15 Innovate Biopharmaceuticals
7.15.1 Innovate Biopharmaceuticals Corporate Summary
7.15.2 Innovate Biopharmaceuticals Business Overview
7.15.3 Innovate Biopharmaceuticals Celiac Drugs Major Product Offerings
7.15.4 Innovate Biopharmaceuticals Celiac Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Innovate Biopharmaceuticals Key News
7.16 Johnson & Johnson
7.16.1 Johnson & Johnson Corporate Summary
7.16.2 Johnson & Johnson Business Overview
7.16.3 Johnson & Johnson Celiac Drugs Major Product Offerings
7.16.4 Johnson & Johnson Celiac Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Johnson & Johnson Key News
7.17 Kedrion Biopharma
7.17.1 Kedrion Biopharma Corporate Summary
7.17.2 Kedrion Biopharma Business Overview
7.17.3 Kedrion Biopharma Celiac Drugs Major Product Offerings
7.17.4 Kedrion Biopharma Celiac Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Kedrion Biopharma Key News
7.18 LFB Group
7.18.1 LFB Group Corporate Summary
7.18.2 LFB Group Business Overview
7.18.3 LFB Group Celiac Drugs Major Product Offerings
7.18.4 LFB Group Celiac Drugs Sales and Revenue in Global (2017-2022)
7.18.5 LFB Group Key News
7.19 Merck
7.19.1 Merck Corporate Summary
7.19.2 Merck Business Overview
7.19.3 Merck Celiac Drugs Major Product Offerings
7.19.4 Merck Celiac Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Merck Key News
7.20 Novartis
7.20.1 Novartis Corporate Summary
7.20.2 Novartis Business Overview
7.20.3 Novartis Celiac Drugs Major Product Offerings
7.20.4 Novartis Celiac Drugs Sales and Revenue in Global (2017-2022)
7.20.5 Novartis Key News
8 Global Celiac Drugs Production Capacity, Analysis
8.1 Global Celiac Drugs Production Capacity, 2017-2028
8.2 Celiac Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Celiac Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Celiac Drugs Supply Chain Analysis
10.1 Celiac Drugs Industry Value Chain
10.2 Celiac Drugs Upstream Market
10.3 Celiac Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Celiac Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Celiac Drugs in Global Market
Table 2. Top Celiac Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Celiac Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Celiac Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Celiac Drugs Sales by Companies, (K MT), 2017-2022
Table 6. Global Celiac Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Celiac Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Celiac Drugs Product Type
Table 9. List of Global Tier 1 Celiac Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Celiac Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Celiac Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Celiac Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Celiac Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Celiac Drugs Sales (K MT), 2017-2022
Table 15. By Type - Global Celiac Drugs Sales (K MT), 2023-2028
Table 16. By Application ? Global Celiac Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Celiac Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Celiac Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Celiac Drugs Sales (K MT), 2017-2022
Table 20. By Application - Global Celiac Drugs Sales (K MT), 2023-2028
Table 21. By Region ? Global Celiac Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Celiac Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Celiac Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Celiac Drugs Sales (K MT), 2017-2022
Table 25. By Region - Global Celiac Drugs Sales (K MT), 2023-2028
Table 26. By Country - North America Celiac Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Celiac Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Celiac Drugs Sales, (K MT), 2017-2022
Table 29. By Country - North America Celiac Drugs Sales, (K MT), 2023-2028
Table 30. By Country - Europe Celiac Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Celiac Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Celiac Drugs Sales, (K MT), 2017-2022
Table 33. By Country - Europe Celiac Drugs Sales, (K MT), 2023-2028
Table 34. By Region - Asia Celiac Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Celiac Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Celiac Drugs Sales, (K MT), 2017-2022
Table 37. By Region - Asia Celiac Drugs Sales, (K MT), 2023-2028
Table 38. By Country - South America Celiac Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Celiac Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Celiac Drugs Sales, (K MT), 2017-2022
Table 41. By Country - South America Celiac Drugs Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Celiac Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Celiac Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Celiac Drugs Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Celiac Drugs Sales, (K MT), 2023-2028
Table 46. ADMA Biologics Corporate Summary
Table 47. ADMA Biologics Celiac Drugs Product Offerings
Table 48. ADMA Biologics Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Amgen Corporate Summary
Table 50. Amgen Celiac Drugs Product Offerings
Table 51. Amgen Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Anthera Pharmaceuticals Corporate Summary
Table 53. Anthera Pharmaceuticals Celiac Drugs Product Offerings
Table 54. Anthera Pharmaceuticals Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Bayer Corporate Summary
Table 56. Bayer Celiac Drugs Product Offerings
Table 57. Bayer Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Biogen Corporate Summary
Table 59. Biogen Celiac Drugs Product Offerings
Table 60. Biogen Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. BioLineRx Corporate Summary
Table 62. BioLineRx Celiac Drugs Product Offerings
Table 63. BioLineRx Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Biotest Corporate Summary
Table 65. Biotest Celiac Drugs Product Offerings
Table 66. Biotest Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Bristol-Myers Squibb Corporate Summary
Table 68. Bristol-Myers Squibb Celiac Drugs Product Offerings
Table 69. Bristol-Myers Squibb Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Celgene Corporate Summary
Table 71. Celgene Celiac Drugs Product Offerings
Table 72. Celgene Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Celimmune Corporate Summary
Table 74. Celimmune Celiac Drugs Product Offerings
Table 75. Celimmune Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. F Hoffmann-La Roche Corporate Summary
Table 77. F Hoffmann-La Roche Celiac Drugs Product Offerings
Table 78. F Hoffmann-La Roche Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. ImmunogenX Corporate Summary
Table 80. ImmunogenX Celiac Drugs Product Offerings
Table 81. ImmunogenX Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 82. Immunomedics Corporate Summary
Table 83. Immunomedics Celiac Drugs Product Offerings
Table 84. Immunomedics Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 85. ImmusanT Corporate Summary
Table 86. ImmusanT Celiac Drugs Product Offerings
Table 87. ImmusanT Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 88. Innovate Biopharmaceuticals Corporate Summary
Table 89. Innovate Biopharmaceuticals Celiac Drugs Product Offerings
Table 90. Innovate Biopharmaceuticals Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 91. Johnson & Johnson Corporate Summary
Table 92. Johnson & Johnson Celiac Drugs Product Offerings
Table 93. Johnson & Johnson Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 94. Kedrion Biopharma Corporate Summary
Table 95. Kedrion Biopharma Celiac Drugs Product Offerings
Table 96. Kedrion Biopharma Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 97. LFB Group Corporate Summary
Table 98. LFB Group Celiac Drugs Product Offerings
Table 99. LFB Group Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 100. Merck Corporate Summary
Table 101. Merck Celiac Drugs Product Offerings
Table 102. Merck Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 103. Novartis Corporate Summary
Table 104. Novartis Celiac Drugs Product Offerings
Table 105. Novartis Celiac Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 106. Celiac Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 107. Global Celiac Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Celiac Drugs Production by Region, 2017-2022 (K MT)
Table 109. Global Celiac Drugs Production by Region, 2023-2028 (K MT)
Table 110. Celiac Drugs Market Opportunities & Trends in Global Market
Table 111. Celiac Drugs Market Drivers in Global Market
Table 112. Celiac Drugs Market Restraints in Global Market
Table 113. Celiac Drugs Raw Materials
Table 114. Celiac Drugs Raw Materials Suppliers in Global Market
Table 115. Typical Celiac Drugs Downstream
Table 116. Celiac Drugs Downstream Clients in Global Market
Table 117. Celiac Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Celiac Drugs Segment by Type
Figure 2. Celiac Drugs Segment by Application
Figure 3. Global Celiac Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Celiac Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Celiac Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Celiac Drugs Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Celiac Drugs Revenue in 2021
Figure 9. By Type - Global Celiac Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Celiac Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Celiac Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Celiac Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Celiac Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Celiac Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Celiac Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Celiac Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Celiac Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Celiac Drugs Sales Market Share, 2017-2028
Figure 19. US Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Celiac Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Celiac Drugs Sales Market Share, 2017-2028
Figure 24. Germany Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Celiac Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Celiac Drugs Sales Market Share, 2017-2028
Figure 33. China Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Celiac Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Celiac Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Celiac Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Celiac Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Celiac Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Celiac Drugs Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Celiac Drugs by Region, 2021 VS 2028
Figure 50. Celiac Drugs Industry Value Chain
Figure 51. Marketing Channels
